Nusrath Sultana - Nov 30, 2021 Form 4 Insider Report for SURMODICS INC (SRDX)

Role: VP, Clinical Affairs
Signature: /s/ John Manders on behalf of Nusrath Sultana
Stock symbol: SRDX
Transactions as of: Nov 30, 2021
Transactions value $: -$18,934
Form type: 4
Date filed: 12/2/2021, 02:10 PM
Next filing: Feb 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRDX	Common Stock	Tax liability	-$18.9K	-431	-6.33%	$43.93	6.38K	Nov 30, 2021	Direct	F1
transaction	SRDX	Common Stock	Award	$0	+910	+14.26%	$0.00	7.29K	Nov 30, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRDX	Employee Stock Option (right to buy)	Award	$0	+3.67K		$0.00	3.67K	Nov 30, 2021	Common Stock	3.67K	$43.93	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 98 shares acquired for the phase ending August 31, 2020 through the Employee Stock Purchase Plan, 78 shares acquired for the phase ending February 26, 2021, and 71 shares acquired for the phase ending August 31, 2021.
F2	The award vests in four equal installments on each of the first four anniversaries of the November 30, 2021 grant date.